Bio Medica Laboratories Board Approves Object Alteration for Major Expansion Plans
The Board of Directors of Bio Medica Laboratories Limited, formerly known as Bio Medica Laboratories Pvt. Ltd., approved significant changes to the company's Memorandum of Association (MOA) during a meeting held on June 22, 2026. These alterations are designed to support and facilitate the company’s planned expansion across various natural product lines.The Board decided that the alteration of the Object Clause ('Main Objects') is subject to shareholder approval through a mandated Postal Ballot Process via E-voting. Furthermore, the Board appointed M/s Vishakha Agrawal & Associates, Practicing Company Secretaries, to serve as the Scrutinizer for the Postal Ballot process, ensuring fairness and transparency in conducting the e-voting.
The meeting commenced at 03:45 PM and concluded at 04:15 PM. The Board also fixed Friday, June 19, 2026, as the cut-off date for determining member eligibility to vote via electronic means regarding these changes.
Scope of Amended Objects
The amendments inserted into the Main Object clause broaden Bio Medica Laboratories’ operational capabilities and market reach. These new objects encompass three primary areas:Manufacturing and Production: The company is authorized to carry on the business of manufacturing, processing, extracting, distilling, refining, blending, formulating, packing, importing, exporting, and dealing in a wide range of specialized products. This includes essential oils other than citrus fruit oils and mint oils, aromatic oils, herbal oils, fragrance oils, plant extracts, floral extracts, spice oils, oleoresins, hydrosols, perfumery compounds, and all other natural or synthetic allied products derived from botanical sources such as herbs, flowers, leaves, roots, seeds, barks, woods, and spices.
Trading and Distribution: The company’s objects now explicitly include purchasing, selling, importing, exporting, marketing, distributing, and acting as an agent or broker for essential oils, aromatic chemicals, perfumery materials, and flavoring substances. These products are intended for use across various industrial and consumer sectors, including pharmaceutical, cosmetic, personal care, food, beverage, wellness, aromatherapy, agricultural, and industrial markets.
Infrastructure Establishment: To support its manufacturing and trading goals, Bio Medica Laboratories is authorized to establish, acquire, lease, operate, and maintain all necessary facilities. This includes factories, processing units, distillation plants, extraction units, laboratories, warehouses, and other infrastructure required for the manufacture, storage, packaging, and subsequent trading of essential oils, aromatic substances, fragrances, natural extracts, and related products.
BMLL Stock Price Movement
Shares of Bio Medica Laboratories Limited today shed 1.83%, closing at ₹139.60 after trading completed. The stock stayed within a volatile intraday range, moving between a low of ₹137.00 and a high of ₹141.55 during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.